Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study.

MLA

Alegre-Sancho, Juan J., et al. “Effectiveness and Persistence of Golimumab as a Second Biological Drug in Patients with Spondyloarthritis: A Retrospective Study.” Medicine, vol. 100, no. 13, Apr. 2021, p. e25223. EBSCOhost, https://doi.org/10.1097/MD.0000000000025223.

APA

Alegre-Sancho, J. J., Juanola, X., Rodríguez-Heredia, J. M., Manero, J., Villa-Blanco, I., Laiz, A., Arteaga, M. J., Cea-Calvo, L., & González, C. M. (2021). Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study. Medicine, 100(13), e25223. https://doi.org/10.1097/MD.0000000000025223

Chicago

Alegre-Sancho, Juan J, Xavier Juanola, José M Rodríguez-Heredia, Javier Manero, Ignacio Villa-Blanco, Ana Laiz, María J Arteaga, Luis Cea-Calvo, and Carlos M González. 2021. “Effectiveness and Persistence of Golimumab as a Second Biological Drug in Patients with Spondyloarthritis: A Retrospective Study.” Medicine 100 (13): e25223. doi:10.1097/MD.0000000000025223.